Rheumatology International

, Volume 32, Issue 3, pp 703–709 | Cite as

Takayasu arteritis: assessment of response to medical therapy based on clinical activity criteria and imaging techniques

  • Daniele Souza Freitas
  • Cintia Zumstein Camargo
  • Henrique Ataíde Mariz
  • Anne Elizabeth Diniz Arraes
  • Alexandre Wagner Silva de Souza
Original Article

Abstract

In this retrospective longitudinal cohort study we included 52 patients with Takayasu arteritis (TA) who were on regular follow-up at the Vasculitis Unit of Universidade Federal de São Paulo between 2003 and 2009. The mean age at study was 38 years and the mean age at diagnosis was 29 years. Patients were followed for a mean 74.3 months. A relapse-remitting course was observed in 41 patients (78.8%) whereas 9 (17.3%) had a monophasic course and only 2 (3.8%) patients were chronic-active. Disease remission was achieved in 50 patients (96.2%). Angiographic type V was observed in 42.3% of TA patients at diagnosis and in 61.5% during follow-up. The most affected arteries were the abdominal aorta (63.5%) and left subclavian (60.6%). Prednisone was used by 94% of TA patients and immunosuppressive agents were prescribed for 51 (98%) patients. Methotrexate was used by 82.7%, followed by cyclophosphamide (26.9%), azathioprine (25.0%), anti-TNFα agents (5.8%) and leflunomide (5.8%). Although, forty patients (76.9%) used prednisone and methotrexate as initial treatment, 75% of them developed new vascular lesions along follow-up. Eighteen TA patients (34.6%) needed to change immunosuppressive therapy due to failure or toxicity, among them 83.3% presented new lesions. Surgical treatment was performed in 34.6% of patients and restenosis was observed in 13.5% in a median time of 11 months after surgery. In conclusion besides prednisone and methotrexate is largely used in TA, the majority of patients still develop new arterial lesions along time.

Keywords

Vasculitides Takayasu arteritis Cohort studies Immunosuppressive agents 

References

  1. 1.
    Kerr GS, Hallahan CW, Giordano J et al (1994) Takayasu Arteritis. Ann Intern Med 120:919–929PubMedGoogle Scholar
  2. 2.
    Johnston SL, Lock RJ, Gompels MM (2002) Takayasu arteritis: a review. J Clin Pathol 55:481–486PubMedCrossRefGoogle Scholar
  3. 3.
    Sato EI, Hatta FS, Levy-Neto M, Fernades S (1998) Demographic, clinical, and angiographic data of patients with Takayasu arteritis in Brazil. Int J Cardiol 66(Supp 1):S67–S70PubMedCrossRefGoogle Scholar
  4. 4.
    Vanoli M, Daina E, Salvarani C et al (2005) Takayasu’s arteritis: a study of 104 italian Patients. Arthritis Rheum 53:100–107PubMedCrossRefGoogle Scholar
  5. 5.
    Soto ME, Espinola N, Flores-Suarez LF, Reyes PA (2008) Takayasu arteritis: clinical features in 110 Mexican Mestizo patients and cardiovascular impact on survival and prognosis. Clin Exp Rheumatol 26(3 Suppl 49):S9–S15PubMedGoogle Scholar
  6. 6.
    Park MC, Lee SW, Park YB, Chung NS, Lee SK (2005) Clinical characteristics and outcomes of Takayasu’s arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification. Scand J Med 34:284–292CrossRefGoogle Scholar
  7. 7.
    Ishikawa K, Maetani S (1994) Long-term outcome of for 120 Japanese patients with Takayasu’s disease: clinical and statistical analysis of related prognostic factors. Circulation 90:1855–1860PubMedGoogle Scholar
  8. 8.
    Sharma BK, Jain S (1998) A possible role of sex in determining distribution of lesions in Takayasu arteritis. Int J Cardiol 66(Suppl 1):S81–S84PubMedCrossRefGoogle Scholar
  9. 9.
    Numano F (1997) Differences in clinical presentation and outcome in different countries for Takayasu’s arteritis. Curr Opin Rheumtol 9:12–15CrossRefGoogle Scholar
  10. 10.
    Numano F, Okawara M, Inomata H, Kobayashi Y (2000) Takayasu’s arteritis. Lancet 356:1023–1025PubMedCrossRefGoogle Scholar
  11. 11.
    Maksimowicz-McKinnon K, Clark TM, Hoffman GS (2007) Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum 56:1000–1009PubMedCrossRefGoogle Scholar
  12. 12.
    Hoffman GS, Leavitt RY, Kerr GS et al (1994) Treatment of glucocorticoid-resistant or relapsing Takayasu artertitis with methotrexate. Arthritis Rheum 37:578–582PubMedCrossRefGoogle Scholar
  13. 13.
    Valsakumar AK, Chirammal Valappil U, Jorapor V et al (2003) Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu’s arteritis. J Rheumatol 30:1793–1798PubMedGoogle Scholar
  14. 14.
    Shinjo SK, Pereira RMR, Tizziani VAP et al (2007) Mycophenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritis. Clin Rheumatol 26:1871–1875PubMedCrossRefGoogle Scholar
  15. 15.
    Daina E, Schieppati A, Remuzzi G (1999) Mycophenolate mofetil for the treatment of Takayasu arteritis. Ann Intern Med 130:422–426PubMedGoogle Scholar
  16. 16.
    Hoffman GS, Merkel PA, Brasington RD et al (2004) Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu’s arteritis. Arthritis Rheum 50:2296–2304PubMedCrossRefGoogle Scholar
  17. 17.
    Molloy ES, Langford CA, Clark TM, Gota CE, Hoffman GS (2008) Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up. Ann Rheum Dis 67:1567–1569PubMedCrossRefGoogle Scholar
  18. 18.
    Hitoshi O, Matsuda H, Minatoya K et al (2008) Overview of late outcome of medical and surgical treatment for Takayasu arteritis. Circulation 118:2738–2747CrossRefGoogle Scholar
  19. 19.
    Hoffman GS, Liang P (2004) Advances in the medical and surgical treatment of Takayasu arteritis. Curr Opin Rheumatol 17:16–24Google Scholar
  20. 20.
    Miyata T, Sato O, Koyama H, Shigematsu H, Tada Y (2003) Long-term survival after surgical treatment of patients with Takayasu`s arteritis. Circulation 23:1474–1480CrossRefGoogle Scholar
  21. 21.
    Arend WP, Michel BA, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Takaysu arteritis. Arthritis Rheum 33:1129–1134PubMedCrossRefGoogle Scholar
  22. 22.
    Hata A, Noda M, Moriwaki R, Numano F (1996) Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol 54(suppl):S155–S163PubMedCrossRefGoogle Scholar
  23. 23.
    Bicakcigil M, Aksu K, Kamali S et al (2009) Takayasu arteritis in Turkey–clinical and angiographic features of 248 patients. Clin Exp Rheumatol 27(Suppl 52):S59–S64PubMedGoogle Scholar
  24. 24.
    Arnaud L, Haroche J, Limal N et al (2010) Takayasu arteritis in France: a single-center retrospective study of 82 cases comparing White, North African and Black patients. Medicine (Baltimore) 89:1–17CrossRefGoogle Scholar
  25. 25.
    Sato EI, Lima DNS, Espirito Santo B, Hata F (2000) Takayasu arteritis–treatment and prognosis in a University Center in Brazil. Int J Cardiol 75:S163–S166PubMedCrossRefGoogle Scholar
  26. 26.
    Jain S, Kumari S, Ganguly NK, Sharma BK (1996) Current status of Takayasu arteritis in India. Int J Cardiol 54(Suppl):S111–S116PubMedCrossRefGoogle Scholar
  27. 27.
    Ueda H, Morooka S, Ito I, Yamaguchi H, Takeda T (1969) Clinical observation of 52 cases of aortitis syndrome. Jpn Heart J 10:277–288PubMedCrossRefGoogle Scholar
  28. 28.
    Karageorgaki ZT, Bertsias GK, Mavragani CP et al (2009) Takayasu arteritis: epidemiological, clinical, and immunogenetic features in Greece. Clin Exp Rheumatol 27(Suppl 52):S33–S39PubMedGoogle Scholar
  29. 29.
    Maksimowicz-McKinnon K, Hoffman GS (2007) Takayasu arteritis: what is the long term prognosis? Rheum Dis Clin N Am 33:777–786CrossRefGoogle Scholar
  30. 30.
    Shelhamer JH, Volkman DJ, Parrillo JE et al (1985) Takayasu`s arteritis and its therapy. Ann Intern Med 103:121–126PubMedGoogle Scholar
  31. 31.
    Park MC, Lee SW, Park YB et al (2006) Post-interventional immunosuppressive treatment and vascular restenosis in Takayasu`s arteritis. Rheumatology (Oxford) 45:600–605CrossRefGoogle Scholar
  32. 32.
    Subramanyan R, Joy J, Balakrishnan KG (1989) Natural history of aortoarteritis (Takayasu`s disease). Circulation 80:429–437PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Daniele Souza Freitas
    • 1
  • Cintia Zumstein Camargo
    • 1
  • Henrique Ataíde Mariz
    • 1
  • Anne Elizabeth Diniz Arraes
    • 1
  • Alexandre Wagner Silva de Souza
    • 1
  1. 1.Rheumatology DivisionUniversidade Federal de São Paulo-UNIFESPSão PauloBrazil

Personalised recommendations